Division of Hematology-Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Blood. 2022 Jun 2;139(22):3264-3277. doi: 10.1182/blood.2020009300.
The inherited thrombocytopenia syndromes are a group of disorders characterized primarily by quantitative defects in platelet number, though with a variety demonstrating qualitative defects and/or extrahematopoietic findings. Through collaborative international efforts applying next-generation sequencing approaches, the list of genetic syndromes that cause thrombocytopenia has expanded significantly in recent years, now with over 40 genes implicated. In this review, we focus on what is known about the genetic etiology of inherited thrombocytopenia syndromes and how the field has worked to validate new genetic discoveries. We highlight the important role for the clinician in identifying a germline genetic diagnosis and strategies for identifying novel causes through research-based endeavors.
遗传性血小板减少症综合征是一组以血小板数量的数量缺陷为主要特征的疾病,尽管有多种疾病表现出质量缺陷和/或造血外发现。通过应用下一代测序方法的国际合作,近年来导致血小板减少症的遗传综合征的清单显著扩大,现在涉及 40 多个基因。在这篇综述中,我们重点介绍遗传性血小板减少症综合征的遗传病因学的已知内容,以及该领域如何努力验证新的遗传发现。我们强调了临床医生在识别种系遗传诊断中的重要作用,以及通过基于研究的努力识别新病因的策略。